ThomasJErvinMD

PubMed

• 159 citations
  Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic ...
  Jeff P. Sharman, Steven Coutre, Richard R. Furman, Bruce D. Cheson, John M. Pagel, Peter Hillmen, Jacqueline C. Barrientos, Andrew D. Zelenetz, Thomas J. Kipps, Ian W....> ;Journal of Clinical Oncology. 2019 Apr 17
• 1279 citations
  Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.
  Richard R. Furman, Jeff P. Sharman, Steven Coutre, Bruce D. Cheson, John M. Pagel, Peter Hillmen, Jacqueline C. Barrientos, Andrew D. Zelenetz, Thomas J. Kipps, Ian W....> ;The New England Journal of Medicine. 2014 Mar 12
• 375 citations
  Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
  David R. Spigel, Thomas Ervin, Rodryg Ramlau, Davey B. Daniel, J. Goldschmidt, George R. Blumenschein, Maciej Krzakowski, Gilles Robinet, Benoit Godbert, Fabrice Barle...> ;Journal of Clinical Oncology. 2013 Nov 10
• 4308 citations
  Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
  Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena, E. Gabriela Chiorean, Jeffrey R. Infante, Malcolm J. Moore, Thomas E. Seay, Sergei Tjulandin, Wen Wee Ma, Mansoo...> ;The New England Journal of Medicine. 2013 Oct 30
• 30 citations
  Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab ...
  Johanna C. Bendell, Thomas J. Ervin, David Gallinson, Jaswinder Singh, James A. Wallace, Mansoor N. Saleh, Marcy Vallone, See-Chun Phan, Stephen P. Hack> ;Clinical Colorectal Cancer. 2013 Sep 1
• 24 citations
  A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced n...
  David R. Spigel, John D. Hainsworth, Dianna Shipley, Thomas J. Ervin, Peter C. Kohler, Eric T. Lubiner, James D. Peyton, David M. Waterhouse, Howard A. Burris, F. Anth...> ;Journal of Thoracic Oncology. 2012 Jan 1
• Final efficacy results from OAM4558g, a randomized phase II study evaluating MetMAb or placebo in combination with erlotinib in advanced NSCLC.
  Spigel DR, Ervin TJ, Ramlau R, Daniel DB, Goldschmidt JH, Blumenschein GR, Krzakowski MJ, Robinet G, Clement-Duchene C, Barlesi F, Govindan R, Patel T, Orlov SV, Werth...> ;J. Clin. Oncol.. 2011-05-20
• 105 citations
  Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.
  John D. Hainsworth, Thomas J. Ervin, Elke K. Friedman, Victor M. Priego, Patrick B. Murphy, Bobby L. Clark, Ruth E. Lamar> ;Cancer. 2010 Aug 1
• Phase II trial of radiation therapy/temozolomide followed by temozolomide/sorafenib in the first-line treatment of glioblastoma multiforme (GBM).
  Lamar RE, Spigel DR, Burris HA, Markus TM, Kuzur M, Ervin T, Fichtel L, Greco FA, Hainsworth JD> ;J. Clin. Oncol.. 2009-05-20
• 1152 citations
  Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
  Marshall R. Posner, Diane Hershock, Cesar R. Blajman, Elizabeth Mickiewicz, Eric Winquist, Vera Gorbounova, Sergei Tjulandin, Dong M. Shin, Kevin J. Cullen, Thomas J. ...> ;The New England Journal of Medicine. 2007 Oct 25
• Gemtuzumab ozogamicin for treatment of relapsing/refractory acute myelogenous leukemia (AML).
  Case DC, Boyd MA, Hedlund JA, Ervin TJ> ;J. Clin. Oncol.. 2006-06-20
• Long term results of pati ents with hairy cell leukemia treated with cladribine.
  Case DC, Ervin TJ, Boyd MA, Aronson FR, Hedlund JA> ;J. Clin. Oncol.. 2005-06-01
• Community practice experience with gefitinib (ZD1839) as treatment for patients with advanced non-small-cell lung cancer (NSCLC) within an expanded access clinical pro...
  Ervin TJ, Toothaker SR> ;J. Clin. Oncol.. 2004-07-15
• 13 citations
  Side effects of chemotherapy. Case 3. Acute interstitial pneumonitis related to gemcitabine.
  Eyal C. Attar, Thomas J. Ervin, Milos J. Janicek, Aaron Deykin, John J. Godleski> ;Journal of Clinical Oncology. 2000 Feb 1
• 46 citations
  Phase II Trial of High-Dose Liposome-Encapsulated Doxorubicin With Granulocyte Colony-Stimulating Factor in Metastatic Breast Cancer
  Charles L. Shapiro, Thomas J. Ervin, L. Welles, N. Azarnia, J. Keating, Daniel F. Hayes> ;Journal of Clinical Oncology. 1999 Apr 1
• 14 citations
  The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary analysis of RTOG 85-03
  Amr Aref, Brian A Berkey, James G. Schwade, John F. Ensley, David E. Schuller, Robert E. Haselow, Thomas J. Ervin, George E. Laramore> ;International Journal of Radiation Oncology, Biology, Physics. 1999 Jan 1
• 23 citations
  Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: A comparative study usin...
  George E. Laramore, Charles B. Scott, David E. Schuller, Robert E. Haselow, Thomas J. Ervin, Robert Wheeler, Muhyi Al-Sarraf, R. Gahbauer, John R. Jacobs, James G. Sch...> ;International Journal of Radiation Oncology, Biology, Physics. 1993 Dec 1
• 72 citations
  Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autogr...
  Michael J. Robertson, Robert J. Soiffer, Arnold S. Freedman, Susan L. Rabinowe, Kenneth C. Anderson, Thomas J. Ervin, Christine Murray, Keith Dear, James D. Griffin, L...> ;Blood. 1992 May 1
• 7 citations
  Phase II trial of ifosfamide and mesna in previously treated patients with non-Hodgkin's lymphoma: Cancer and Leukemia Group B study 8552.
  James Anderson, Thomas J. Ervin, Arlan J. Gottlieb> ;Hematological Oncology. 2006 Jul 1
• 3 citations
  Cisplatin, continuous-infusion 5-fluorouracil, and intermediate-dose methotrexate in the treatment of unresectable non-small cell carcinoma of the lung.
  Catherine Wheeler, Lawrence N. Shulman, Steven E. Come, Lowell E. Schnipper, Thomas J. Ervin> ;Cancer. 1991 Feb 15
• 46 citations
  Waldenström's Macroglobulinemia: Long-Term Results with the M-2 Protocol
  Thomas J. Ervin, Marjorie A. Boyd, Dennis L. Redfield> ;Cancer Investigation. 1991 Jan 1
• 299 citations
  Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034
  George E. Laramore, Charles Scott, Muhyi Al-Sarraf, Robert E. Haselow, Thomas J. Ervin, Robert Wheeler, John R. Jacobs, David E. Schuller, R. Gahbauer, James G. Schwad...> ;International Journal of Radiation Oncology, Biology, Physics. 1991 Jan 1
• 24 citations
  Phase II study of oral idarubicin in favorable histology non-Hodgkin's lymphoma.
  Daniel M. Hayes, Marjam Gerber, Richard A. Gams, Thomas J. Ervin, Brian M. Dorsk> ;Cancer Research. 1990 Nov 1
• 14 citations
  Phase I-II Study of Epirubicin in Multiple Myeloma
  Thomas J. Ervin, Richard A. Gams, Henry Sonneborn, Stephen Paul, Fred B. Oldham> ;Cancer Research. 1988 Nov 1
• 11 citations
  Phase II trial of ifosfamide and mesna in previously treated patients with non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study 8552.
  James Anderson, Thomas J. Ervin, Arlan J. Gottlieb> ;Medical and Pediatric Oncology. 1988 Jan 1
• Join now to see all